fda warning compounded tirzepatide versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Connecticut Attorney General warning about

If you are having trouble getting medication covered, find a provider with experience with these medications who will be an advocate, says Michelle Pearlman, MD, CEO and co-founder of Prime Institute and ByteMD, who is board-certified in internal medicine, gastroenterology, and obesity medicine

Katout M, Zhu H, Rutsky J, Shah P, Brook RD, Zhong J, et al

This is why Mounjaro is covered by most insurance companies while Zepbound is not

Dihexa appears in research contexts involving HGF/c-Met pathway research, neurotrophic signaling models, cognitive pathway studies

10.1007/s12325-011-0088-z 36

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors a novel mechanism not shared by currently licensed treatments such as semaglutide or tirzepatide